Head lice infestations: A clinical update

Paediatrics and Child Health

Volumn 13, Issue 8, 2008, Pages 692-696

  Bortolussi, Robert ^a   Finlay, Jane ^b   Moore, Dorothy L ^c   Robinson, Joan L ^b   Rousseau Harsany, Élisabeth ^d   Samson, Lindy M ^e   MacDonald, Noni E ^a   Allen, Upton D ^f   Hui, Charles P S ^e   Le Saux, Nicole ^e   Pickering, Larry ^b   Salvadori, Marina I ^g  

^a IWK HEALTH CENTRE   (Canada)

^b The Montreal Children's Hospital ^*

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; LINDANE; MARGARINE; MYRISTIC ACID ISOPROPYL ESTER; OLIVE OIL; PERMETHRIN; PETROLATUM; PYRETHRIN; TRIMETHOPRIM SULFATE;

APPLICATION SITE ERYTHEMA; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL TRIAL; DRUG EFFICACY; HAIR DISEASE; HUMAN; INFESTATION; MICROSCOPY; NEUROTOXICITY; NIT; NONHUMAN; PARASITE IDENTIFICATION; PARASITE IMMUNITY; PARASITE TRANSMISSION; PEDICULUS; PERSONAL HYGIENE; POPULATION RESEARCH; PREVALENCE; PRIMARY SCHOOL; PRURITUS; SCALP HAIR; SINGLE DRUG DOSE; UNITED KINGDOM;

EID: 57649088861     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/13.8.692     Document Type: Article

References (31)

1. Gratz NG. Human lice: Their prevalence, control and resistance to insecticides: A review 1985-1997. Geneva: World Health Organization, 1997. (Version current at August 20, 2008).
2. Public Health Medicine Environmental Group. Head lice: Evidence-based guidelines based on the Stafford Report 2008 update. (Version current at July 4, 2008).
3. Harris J, Crawshaw JG, Millership S. Incidence and prevalence of head lice in a district health authority area. Commun Dis Public Health 2003;6:246-9.
4. Canadian Paediatric Society, Infectious Diseases and Immunization Committee [Principal author: N. MacDonald]. Head lice infestations: A persistent itchy 'pest'. Paediatr Child Health 1996;1:237-40.
5. Roberts RJ. Clinical practice. Head lice. N Engl J Med 2002;346:1645-50.
6. Jones KN, English JC III. Review of common therapeutic options in the United States for the treatment of pediculosis capitis. Clin Infect Dis 2003;36:1355-61.
7. Nash B. Treating head lice. BMJ 2003;326:1256-8.
8. Meinking TA. Infestations. Curr Probl Dermatol 1999;11:73-120.
9. Burkhart CN. Fomite transmission with head lice: A continuing controversy. Lancet 2003;361:99-100.
10. Frankowski BL, Weiner LB; American Academy of Pediatrics, Committee on School Health, Committee on Infectious Diseases. Head lice. Pediatrics 2002;110:638-43.
11. Speare R, Cahill C, Thomas G. Head lice on pillows, and strategies to make a small risk even less. Int J Dermatol 2003;42:626-9.
12. Speare R, Thomas G, Cahill C. Head lice are not found on floors in primary school classrooms. Aust N Z J Public Health 2002;26:208-11.
13. Mumcuoglu KY, Friger M, Ioffe-Uspensky I, Ben-Ishai F, Miller J. Louse comb versus direct visual examination for the diagnosis of head louse infestations. Pediatr Dermatol 2001;18:9-12.
14. Pollack RJ, Kiszewski AE, Spielman A. Overdiagnosis and consequent mismanagement of head louse infestations in North America. Pediatr Infect Dis J 2000;19:689-93.
15. Williams LK, Reichert MA, MacKenzie WR, Hightower AW, Blake PA. Lice, nits and school policy. Pediatrics 2001;107:1011-5.
16. Dodd CS. Interventions for treating headlice (Cochrane review). Cochrane Database Syst Rev 2001;3:CD001165.
17. Centre for Drug Evaluation and Research. FDA public health advisory: Safety of topical lindane products for the treatment of scabies and lice. (Version current at May 21, 2008).
18. Humphreys EH, Janssen S, Heil A, Hiatt P, Solomon G, Miller MD. Outcomes of the California ban on pharmaceutical lindane: Clinical and ecologic impacts. Environ Health Perspect 2008;116:297-302.
19. Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med 1999;153:969-73.
20. Pollack RJ. Head lice infestations: Single drug versus combination therapy. Pediatrics 2001;108:1393.
21. Downs AM. Managing head lice in an era of increasing resistance to insecticides. Am J Clin Dermatol 2004;5:169-177.
22. Hipolito RB, Mallorca FG, Zuniga-Macaraig ZO, Apolinario PC, Wheeler-Sherman J. Head lice infestations: Single drug versus combination therapy with one percent permethrin and trimethoprim/ sulfamethoxazole. Pediatrics 2001;107:E30.
23. Health Canada. Drugs and health products. (Version current at August 21, 2008).
24. Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet combing with malathion for treatment of head lice in the UK: A pragmatic randomized controlled trial. Lancet 2000;356:540-4.
25. Meinking TL, Clineschmidt CM, Chen C, et al. An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice. J Pediatr 2002;141:665-70.
26. Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4% dimeticone lotion: Randomized controlled equivalence. BMJ 2005;330:1423.
27. Kaul N, Palma KG, Silagy SS, Goodman JJ, Toole J. North American efficacy and safety of a novel pediculicide rinse, isopropyl myristate 50% (Resultz). J Cutan Med Surg 2007;11:161-7.
28. Burgess IF, Lee PN, Brown CM. Randomised, controlled, parallel group clinical trials to evaluate the efficacy of isopropyl myristate/ cyclomethicone solution against head lice. Pharm J 2008;280:371-5.
29. Burgess IF, Lee PN, Matlock G. Randomised, controlled, assessor blind trial comparing 4%. dimeticone lotion with 0.5% malathion liquid for head louse infestation. PLoS ONE 2007;2:e1127.
30. Mumcuoglu KY, Miller J, Zamir C, Zentner G, Helbin V, Ingber A. The in vivo pediculocidal efficacy of a natural remedy. Isr Med Assoc J 2002;4:790-3.
31. The National Pediculosis Association. (Version current at August 21, 2008).